Unimed Pharma
Private Company
Funding information not available
Overview
Unimed Pharma is a well-established, private Slovak company focused on the ophthalmic sector, operating as a manufacturer and marketer of over-the-counter (OTC) eye care products and dietary supplements. It leverages its own R&D and quality control to produce a portfolio aimed at conditions like dry eye, conjunctivitis, and general eye health support, utilizing specialized packaging like the Novelia® system for preservative-free formulations. The company appears to be revenue-generating with a commercial-stage portfolio, targeting the Central European market through collaborations with eye doctors, clinics, and pharmacies. Its strategy is built on decades of experience, proven quality, and addressing common eye health needs rather than novel drug development for neurological disorders as previously indicated.
Technology Platform
Formulation expertise and specialized drug delivery for ophthalmic products, including preservative-free multi-dose packaging (Novelia® system).
Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive OTC ophthalmology market against giants like Alcon, Bausch + Lomb, and Thea Pharmaceutical. Competes on the basis of regional trust, specialized preservative-free packaging, and direct HCP relationships rather than blockbuster novel drugs.